Advertisement

Related Videos

Deborah Collyar: What's In It for Patients?

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Jul
02
Today In Oncology
Real-World Heart and Lung Radiation Doses From NHS Breast Radiotherapy Plans
Previously Untreated Advanced NSCLC With High PD-L1 Expressionb PD-1/-L1 Inhibitor Monotherapy or Chemoimmunotherapy
Break Through Cancer and the Lustgarten Foundation Launch New Pancreatic Cancer Initiative
AACR Statement and Call to Action Concerning OMB Proposal
Breast Cancer Palbociclib-Based Regimen Approved for HR-Positive, HER2-Positive Metastatic Disease
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo